Editorial: Medication Safety in COVID-19 Management

Editorial: Medication Safety in COVID-19 Management

Bibliographic Details
Main Author:	Saibal Das
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Pharmacology
Subjects:	COVID-19 pharmacotherapeutics medication safety drug development
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.940307/full

Similar Items

Editorial: Medication safety in COVID-19 management, Volume II
by: Saibal Das, et al.
Published: (2023-03-01)

Prospective of extracellular matrix and drug correlations in disease management
by: Varish Ahmad
Published: (2021-03-01)

Negative Outcomes Associated with Medication in Neonates on Parenteral Nutrition Therapy
by: Evelin Nataly Vega Díaz, et al.
Published: (2023-06-01)

CHOICE OF DRUGS BY A GRADUATOR OF A MEDICAL UNIVERSITY IN INDIVIDUAL STANDARD SITUATIONS OF OUTPATIENT PRACTICE
by: S. V. Gatsura, et al.
Published: (2018-01-01)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015-12-01)

Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic, Minas Gerais, Brazil
by: ANDREZA R.V. LOPES, et al.

Rosacea pathogenesis and therapeutics: current treatments and a look at future targets
by: Garrett W. Fisher, et al.
Published: (2023-12-01)

Steroid stewardship
by: Sanjay Kalra, et al.
Published: (2022-01-01)

Possible Mechanisms of the Interplay between Drugs and Mycotoxins—Is There a Possible Impact?
by: Orphélie Lootens, et al.
Published: (2022-12-01)

In the Eye of the Storm: The Role of the Pharmacist in Medication Safety during the COVID-19 Pandemic at an Urban Teaching Hospital
by: Abir O. Kanaan, et al.
Published: (2020-11-01)

Evaluation of the Pharmacotherapeutic Pattern for Treating Schizophrenia in Bangladesh
by: Salsabil Islam, et al.
Published: (2020-06-01)

Monitoring biochemical markers during pharmacotherapeutic follow-up of type 2 diabetic patients
by: Luciana Macatrão Nogueira Nunes, et al.
Published: (2012-07-01)

Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and current co-therapeutic approaches
by: Nick Giannoukakis, et al.
Published: (2023-07-01)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
by: Cheng Xue Qin, et al.
Published: (2020-11-01)

Safety and Efficacy of Antiviral Drugs for the Treatment of COVID-19: A Systematic Review
by: Nie Z, et al.
Published: (2022-08-01)

Food Safety Knowledge, Attitudes, and Self-Reported Practices Among Medical Staff in China Before, During and After the COVID-19 Pandemic
by: Luo L, et al.
Published: (2021-12-01)

Pharmacokinetic/Pharmacodynamic Modeling and Application in Antibacterial and Antifungal Pharmacotherapy: A Narrative Review
by: Laiz Campos Pereira, et al.
Published: (2022-07-01)

The importance of pharmacotherapeutical follow-up in hospital discharge
by: L. C. P. Oliveira, et al.
Published: (2020-11-01)

Contribuição do uso de medicamentos para a admissão hospitalar
by: Patrícia de Carvalho Mastroianni, et al.
Published: (2009-03-01)

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety
Published: (2020-12-01)

Natural products of relevance in the management of attention deficit hyperactivity disorder
by: Luísa Custódio, et al.
Published: (2023-02-01)

Safety of air medical transport of patients with COVID‐19 by personnel using routine personal protective equipment
by: Darren Braude, et al.
Published: (2021-04-01)

Safety of psychotropic medications in people with COVID-19
by: G. Ostuzzi, et al.
Published: (2021-04-01)

Impact of Bee Venom Enzymes on Diseases and Immune Responses
by: Md. Sakib Hossen, et al.
Published: (2016-12-01)

Quality of life of HIV+ patients undergoing pharmacotherapeutic follow-up
by: Catarine Vitor Loureiro, et al.
Published: (2012-12-01)

COVID 19 and vaccine safety
by: Przemysław Raczkiewicz, et al.
Published: (2021-11-01)

COVID 19 and vaccine safety
by: Przemysław Raczkiewicz, et al.
Published: (2021-08-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01)

Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients
by: Mathumalar Loganathan Fahrni, et al.
Published: (2023-01-01)

Perceptions of personal safety hazards in the context of the COVID-19 pandemic by USA and Russian medical staff
by: Konstantin N. Tsaranov, et al.
Published: (2020-01-01)

Evaluation of COVID-19 Patient Safety Compared to Non-COVID-19 Patients and Predisposing Factors of Nursing Errors
by: Leila Mohammadnahal, et al.
Published: (2022-07-01)

Changes to primary care delivery during the COVID-19 pandemic and perceived impact on medication safety: A survey study
by: Laura L. Gleeson, et al.
Published: (2022-06-01)

Allergy-Related Medication Error Reports Submitted to a Large Patient Safety Reporting System
by: Matthew Grissinger, et al.
Published: (2019-09-01)

Prevalence and Factors Related to Self-Medication for COVID-19 Prevention in the Elderly
by: Narjes Heshmatifar, et al.
Published: (2021-03-01)

Review: Medical Waste Management for Covid19
by: Hendri Sutrisno, et al.
Published: (2020-09-01)

Can pharmaceutical care decrease the oxidative stress in type 2 diabetes mellitus?
by: Angélica Marchesi Lira-Meriguete, et al.
Published: (2024-02-01)

The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
by: Paul D. Terry, et al.
Published: (2023-07-01)

Development of unconventional treatments for mastitis in dairy cattle
by: Aigerim A. Kukeeva, et al.
Published: (2023-04-01)

THREE LEVELS MODEL FOR DIFFERENTIATED PHARMACIST CLINICAL ACTIVITIES IN THE COMMUNITY PHARMACY – THE PROPOSAL
by: Mónica Condinho, et al.
Published: (2014-06-01)

Three Levels Model for Differentiated Pharmacist Clinical Activities in the Community Pharmacy – the Proposal
by: Mónica Condinho, et al.
Published: (2014-04-01)